SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

Share Price is delayed by 15 minutes
Get Live Data
443.00    10.00 (2.31%)
Bid:
440.00
Ask:
443.00
Spread: 3.00 (0.682%)
Market Cap: £218.72m
CLIG Live PriceLast checked at - London Stock Exchange

Intraday City Lon Inv Share Chart

Interim Management Statement

7 Oct 2013 07:00

RNS Number : 8214P
City of London Investment Group PLC
07 October 2013
 



7th October 2013

CITY OF LONDON INVESTMENT GROUP PLC

("City of London", "the Company" or "the Group")

INTERIM MANAGEMENT STATEMENT

 

AGM Trading Update

City of London (LSE: CLIG), a leading emerging markets asset management group, provides an Interim Management Statement for the period 31st May 2013 to 30th September 2013. City of London's Annual General Meeting is being held today.

 

Funds under Management

As at 30th September 2013, FuM were US$3.4 billion (£2.1 billion). This compares to US$3.7 billion (£2.4 billion) at the Company's year-end on 31st May 2013. In US dollar terms, allowing for client withdrawals, this represents a fall of 8% against the MSCI Emerging Markets Index, which fell by 1% over the same period. With the September reopening of the core emerging markets strategy we are able to report the first major mandate win, with expected funding in the fourth quarter of 2013.

 

Operations

The Group's income accrues at a weighted average rate of approximately 92 basis points, net of commissions. Costs remain under control with "fixed" costs in line with budget at £0.8 million per month, and accordingly the current run-rate for operating profit, before profit-share at 30%, is approximately £0.8 million per month based upon current FuM and a US$/£ exchange rate of US$1.6 to £1. The Group estimates that post-tax profit for the first four months of the year will be approximately £1.6 million.

We continue to raise the profile of the diversification products with prospects and consultants. This includes the China A Share CEF strategy, where we are awaiting approval for our second tranche of US$100 million in Qualified Foreign Institutional Investor quota.

 

Dividends

The final dividend of 16 pence per share, subject to approval at today's AGM, will be paid on 25th October 2013, bringing the total dividend for the financial year 2012-13 to 24 pence. Encouraged by both recent marketing success and a recovery in emerging markets, the Board is hopeful that run-rate profits will be sufficient to maintain the dividend during the current year, although this is likely to require a continued relaxation of the Group's 1.5 x dividend cover policy.

 

Remuneration Policy

The Board is aware of understandable concerns by shareholders with regard to the firm's remuneration policy.

Firstly as regards the compensation payments paid to the former CEO and FD, these were made after very extensive consultation and negotiation and were, in the unanimous opinion of the Board, made in the best interests of the company and its shareholders. Regrettably the Compromise Agreements entered into prevent the disclosure of any further information in connection with those payments. 

Secondly, as regards the firm's ESOP programme, the Board is again unanimous that it is in the best interests of CLIG. It should be noted that the shares issued are non-dilutive as they are purchased in the market, no new shares are issued, and, most importantly, our clients continue to emphasise the desirability of significant staff participation in the equity of CLIG.

 

Board composition

As previously announced, Barry Aling joined the Board on 1st August 2013. He has assumed the role of Audit Committee Chair. Allan Bufferd is the Senior Independent Director and Chairs the Remuneration Committee. Rian Dartnell is the Nominations Committee Chair.

 

Half year results for the six months to 30th November 2013 will be announced on 20th January 2014.

 

 

For further information please visit www.citlon.co.uk or contact:

Barry Olliff (CEO)

City of London Investment Group PLC

Tel: 001 610 380 2911

 

 Martin Green

 Canaccord Genuity Limited

 Financial Adviser & Broker

Tel: +44 (0)20 7523 8000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFMMGGVDFGFZM
Date   Source Headline
22nd Sep 201711:08 amRNSHolding(s) in Company
18th Sep 20177:00 amRNSFinal Results
8th Sep 20177:53 amRNSDirector/PDMR Shareholding
31st Aug 20174:00 pmRNSOpen letter to the board of icapital.biz Berhad
20th Jul 20176:22 pmRNSHolding(s) in Company
19th Jul 20177:00 amRNSTrading Update
13th Jul 20176:15 pmRNSHolding(s) in Company
13th Jul 20177:00 amRNSChange of announcement date
13th Jun 20174:26 pmRNSBoard Changes
26th May 20173:49 pmRNSDirector/PDMR Shareholding
25th May 20172:12 pmRNSDirector/PDMR Shareholding
22nd May 201712:56 pmRNSHolding(s) in Company
8th May 20176:03 pmRNSShare Buyback and Total Voting Rights
26th Apr 20173:37 pmRNSHolding(s) in Company
18th Apr 20171:56 pmRNSDirector/PDMR Shareholding
11th Apr 20177:00 amRNSTrading Update
3rd Apr 201712:42 pmRNSHolding(s) in Company
24th Mar 20172:28 pmRNSHolding(s) in Company
21st Mar 20175:20 pmRNSHolding(s) in Company
22nd Feb 20171:40 pmRNSDirector/PDMR Shareholding
22nd Feb 20171:37 pmRNSDirector/PDMR Shareholding
20th Feb 20177:46 amRNSHALF YEAR RESULTS TO 31ST DECEMBER 2016
24th Jan 20173:24 pmRNSHardman Research:Q2 statement robust profitability
17th Jan 20177:00 amRNSFunds Under Management - Trading Update
24th Nov 20163:42 pmRNSDirector/PDMR Shareholding
19th Oct 201611:15 amRNSAGM resolutions
17th Oct 20165:49 pmRNSResult of AGM
13th Oct 20163:05 pmRNSDirector/PDMR Shareholding
11th Oct 20165:13 pmRNSHolding(s) in Company
11th Oct 20162:51 pmRNSDirector/PDMR Shareholding
10th Oct 20167:46 amRNSAGM Trading Update - 1st Qtr Funds under Mgmt
15th Sep 20169:46 amRNSLetter to icapital.biz Berhad
14th Sep 20169:32 amRNSHardman Report: Exchange rate moves give big boost
12th Sep 20167:00 amRNSFINAL RESULTS FOR THE YEAR TO 30TH JUNE 2016
18th Jul 20167:00 amRNSTrading Update
1st Jul 20167:00 amRNSBlock listing cancellation & block listing return
30th Jun 20164:40 pmRNSSecond Price Monitoring Extn
30th Jun 20164:35 pmRNSPrice Monitoring Extension
23rd Jun 20165:55 pmRNSDirector/PDMR Shareholding
14th Apr 201612:38 pmRNSHardman & Co Issues Research Report
22nd Feb 201611:18 amRNSDirector/PDMR Shareholding
15th Feb 20167:00 amRNSHalf Yearly Report
5th Feb 20164:40 pmRNSSecond Price Monitoring Extn
5th Feb 20164:35 pmRNSPrice Monitoring Extension
29th Jan 20164:41 pmRNSSecond Price Monitoring Extn
29th Jan 20164:35 pmRNSPrice Monitoring Extension
27th Jan 20164:40 pmRNSSecond Price Monitoring Extn
27th Jan 20164:35 pmRNSPrice Monitoring Extension
13th Jan 20169:57 amRNSHardman Issues Research Report
12th Jan 20167:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.